These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 27439020)

  • 41. Detection of the Middle East respiratory syndrome coronavirus in dromedary camel's seminal plasma in Saudi Arabia 2015-2017.
    Hemida MG; Waheed M; Ali AM; Alnaeem A
    Transbound Emerg Dis; 2020 Nov; 67(6):2609-2614. PubMed ID: 32374945
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High Prevalence of MERS-CoV Infection in Camel Workers in Saudi Arabia.
    Alshukairi AN; Zheng J; Zhao J; Nehdi A; Baharoon SA; Layqah L; Bokhari A; Al Johani SM; Samman N; Boudjelal M; Ten Eyck P; Al-Mozaini MA; Zhao J; Perlman S; Alagaili AN
    mBio; 2018 Oct; 9(5):. PubMed ID: 30377284
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Risk Factors for Primary Middle East Respiratory Syndrome Coronavirus Illness in Humans, Saudi Arabia, 2014.
    Alraddadi BM; Watson JT; Almarashi A; Abedi GR; Turkistani A; Sadran M; Housa A; Almazroa MA; Alraihan N; Banjar A; Albalawi E; Alhindi H; Choudhry AJ; Meiman JG; Paczkowski M; Curns A; Mounts A; Feikin DR; Marano N; Swerdlow DL; Gerber SI; Hajjeh R; Madani TA
    Emerg Infect Dis; 2016 Jan; 22(1):49-55. PubMed ID: 26692185
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MERS-CoV spike protein: Targets for vaccines and therapeutics.
    Wang Q; Wong G; Lu G; Yan J; Gao GF
    Antiviral Res; 2016 Sep; 133():165-77. PubMed ID: 27468951
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MERS coronavirus in dromedary camel herd, Saudi Arabia.
    Hemida MG; Chu DK; Poon LL; Perera RA; Alhammadi MA; Ng HY; Siu LY; Guan Y; Alnaeem A; Peiris M
    Emerg Infect Dis; 2014 Jul; 20(7):1231-4. PubMed ID: 24964193
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development of Middle East Respiratory Syndrome Coronavirus vaccines - advances and challenges.
    Cho H; Excler JL; Kim JH; Yoon IK
    Hum Vaccin Immunother; 2018 Feb; 14(2):304-313. PubMed ID: 29048984
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The prevalence of Middle East respiratory Syndrome coronavirus (MERS-CoV) infection in livestock and temporal relation to locations and seasons.
    Kasem S; Qasim I; Al-Doweriej A; Hashim O; Alkarar A; Abu-Obeida A; Saleh M; Al-Hofufi A; Al-Ghadier H; Hussien R; Al-Sahaf A; Bayoumi F; Magouz A
    J Infect Public Health; 2018; 11(6):884-888. PubMed ID: 29396257
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Humoral Immunogenicity and Efficacy of a Single Dose of ChAdOx1 MERS Vaccine Candidate in Dromedary Camels.
    Alharbi NK; Qasim I; Almasoud A; Aljami HA; Alenazi MW; Alhafufi A; Aldibasi OS; Hashem AM; Kasem S; Albrahim R; Aldubaib M; Almansour A; Temperton NJ; Kupke A; Becker S; Abu-Obaidah A; Alkarar A; Yoon IK; Azhar E; Lambe T; Bayoumi F; Aldowerij A; Ibrahim OH; Gilbert SC; Balkhy HH
    Sci Rep; 2019 Nov; 9(1):16292. PubMed ID: 31705137
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Middle East Respiratory Syndrome Vaccine Candidates: Cautious Optimism.
    Schindewolf C; Menachery VD
    Viruses; 2019 Jan; 11(1):. PubMed ID: 30658390
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Middle East Respiratory Syndrome (MERS) coronavirus seroprevalence in domestic livestock in Saudi Arabia, 2010 to 2013.
    Hemida MG; Perera RA; Wang P; Alhammadi MA; Siu LY; Li M; Poon LL; Saif L; Alnaeem A; Peiris M
    Euro Surveill; 2013 Dec; 18(50):20659. PubMed ID: 24342517
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Middle East respiratory syndrome coronavirus vaccines: current status and novel approaches.
    Okba NM; Raj VS; Haagmans BL
    Curr Opin Virol; 2017 Apr; 23():49-58. PubMed ID: 28412285
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genetic Evidence of Middle East Respiratory Syndrome Coronavirus (MERS-Cov) and Widespread Seroprevalence among Camels in Kenya.
    Ommeh S; Zhang W; Zohaib A; Chen J; Zhang H; Hu B; Ge XY; Yang XL; Masika M; Obanda V; Luo Y; Li S; Waruhiu C; Li B; Zhu Y; Ouma D; Odendo V; Wang LF; Anderson DE; Lichoti J; Mungube E; Gakuya F; Zhou P; Ngeiywa KJ; Yan B; Agwanda B; Shi ZL
    Virol Sin; 2018 Dec; 33(6):484-492. PubMed ID: 30570714
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MERS-CoV spike nanoparticles protect mice from MERS-CoV infection.
    Coleman CM; Venkataraman T; Liu YV; Glenn GM; Smith GE; Flyer DC; Frieman MB
    Vaccine; 2017 Mar; 35(12):1586-1589. PubMed ID: 28237499
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular Evolution and Structural Mapping of N-Terminal Domain in Spike Gene of Middle East Respiratory Syndrome Coronavirus (MERS-CoV).
    Naeem A; Hamed ME; Alghoribi MF; Aljabr W; Alsaran H; Enani MA; Alosaimi B
    Viruses; 2020 May; 12(5):. PubMed ID: 32370153
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prospects for a MERS-CoV spike vaccine.
    Zhou Y; Jiang S; Du L
    Expert Rev Vaccines; 2018 Aug; 17(8):677-686. PubMed ID: 30058403
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Middle East Respiratory Syndrome (MERS) Virus-Pathophysiological Axis and the Current Treatment Strategies.
    Alnuqaydan AM; Almutary AG; Sukamaran A; Yang BTW; Lee XT; Lim WX; Ng YM; Ibrahim R; Darmarajan T; Nanjappan S; Chellian J; Candasamy M; Madheswaran T; Sharma A; Dureja H; Prasher P; Verma N; Kumar D; Palaniveloo K; Bisht D; Gupta G; Madan JR; Singh SK; Jha NK; Dua K; Chellappan DK
    AAPS PharmSciTech; 2021 Jun; 22(5):173. PubMed ID: 34105037
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An overview of Middle East respiratory syndrome coronavirus vaccines in preclinical studies.
    Zhang N; Shang J; Li C; Zhou K; Du L
    Expert Rev Vaccines; 2020 Sep; 19(9):817-829. PubMed ID: 32842811
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MERS Vaccine Candidate Offers Promise, but Questions Remain.
    Menachery VD
    EBioMedicine; 2015 Oct; 2(10):1292-3. PubMed ID: 26629514
    [No Abstract]   [Full Text] [Related]  

  • 59. Middle East respiratory syndrome: current status and future prospects for vaccine development.
    Du L; Jiang S
    Expert Opin Biol Ther; 2015; 15(11):1647-51. PubMed ID: 26414077
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development.
    Kim E; Erdos G; Huang S; Kenniston TW; Balmert SC; Carey CD; Raj VS; Epperly MW; Klimstra WB; Haagmans BL; Korkmaz E; Falo LD; Gambotto A
    EBioMedicine; 2020 May; 55():102743. PubMed ID: 32249203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.